Further, highlighting the pro-thrombotic nature of the stenotic valve, this study confirmed the presence of tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1), reinforcing earlier findings that suggest the aortic stenotic valve is a contributor to systemic thromboembolic risk, including stroke [60]. Here, SERPINE1 is linked to Stroke.